A Phase IIIb, multi-center, double-blind, placebo-contro

  • Shepela, Chris (PI)

Project: Research project

Project Details

Description

A Phase IIIb, multi-center, double-blind, placebo-controlled, randomized trial to examine the corticosteroid-sparing effect of certolizumab pegol(COSPAR 1)
StatusFinished
Effective start/end date8/10/0612/31/08

Funding

  • Pharmaceutical Product Development, Inc.